sildenafil citrate
Generic: sildenafil citrate
Labeler: asclemed usa, inc.Drug Facts
Product Profile
Brand Name
sildenafil citrate
Generic Name
sildenafil citrate
Labeler
asclemed usa, inc.
Dosage Form
TABLET
Routes
Active Ingredients
sildenafil citrate 20 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
76420-613
Product ID
76420-613_05373fec-0f63-7fd4-e063-6394a90af72d
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA091479
Listing Expiration
2026-12-31
Marketing Start
2012-11-06
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
76420613
Hyphenated Format
76420-613
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
sildenafil citrate (source: ndc)
Generic Name
sildenafil citrate (source: ndc)
Application Number
ANDA091479 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 20 mg/1
Packaging
- 30 TABLET in 1 BOTTLE (76420-613-30)
- 60 TABLET in 1 BOTTLE (76420-613-60)
- 90 TABLET in 1 BOTTLE (76420-613-90)
Packages (3)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "05373fec-0f63-7fd4-e063-6394a90af72d", "openfda": {"unii": ["BW9B0ZE037"], "rxcui": ["577033"], "spl_set_id": ["49a95b25-08b3-4cfe-a60b-c5132c280be2"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (76420-613-30)", "package_ndc": "76420-613-30", "marketing_start_date": "20230913"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (76420-613-60)", "package_ndc": "76420-613-60", "marketing_start_date": "20230913"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (76420-613-90)", "package_ndc": "76420-613-90", "marketing_start_date": "20230913"}], "brand_name": "SILDENAFIL CITRATE", "product_id": "76420-613_05373fec-0f63-7fd4-e063-6394a90af72d", "dosage_form": "TABLET", "pharm_class": ["Phosphodiesterase 5 Inhibitor [EPC]", "Phosphodiesterase 5 Inhibitors [MoA]"], "product_ndc": "76420-613", "generic_name": "SILDENAFIL CITRATE", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "SILDENAFIL CITRATE", "active_ingredients": [{"name": "SILDENAFIL CITRATE", "strength": "20 mg/1"}], "application_number": "ANDA091479", "marketing_category": "ANDA", "marketing_start_date": "20121106", "listing_expiration_date": "20261231"}